Moreover, a significant positive correlation was found between EpCAM/CD166 phenotypes expression and tumor stage (P = 0.03), tumor differentiation (P = 0.05), neural, and lymph node invasion (P =0.01). This evidence concerns the gene EPCAM and neoplasm.